Companies / Fennec Pharmaceuticals Inc. / Activity
Activity — Fennec Pharmaceuticals Inc.
78 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Raykov Rosty Director | Sell | Common shares | $93.8K | -10K -6.97% | 130,079 0.37% of shares | low |
| Mar 2, 2026 | Raykov Rosty Director | Sell | Common shares | $84.3K | -10K -8.84% | 103,996 0.30% of shares | low |
| Feb 2, 2026 | Raykov Rosty Director | Sell | Common shares | $80.3K | -10K -9.51% | 98,477 0.28% of shares | low |
| Jan 2, 2026 | Raykov Rosty Director | Sell | Common shares | $78.4K | -10K -10.49% | 88,020 0.25% of shares | low |
| May 1, 2026 | Raykov Rosty Director | Sell | Common shares | $69.8K | -11K -8.15% | 121,451 0.35% of shares | low |
| Apr 1, 2026 | Raykov Rosty Director | Sell | Common shares | $69.1K | -11K -8.77% | 113,856 0.33% of shares | low |
| Mar 26, 2026 | Andrade Robert Executive | Exercise | Common shares | $66.7K | +13K +5.37% | 256,656 0.74% of shares | low |
| May 11, 2026 | Rallis Chris a Director | Sell | Common Shares | $58.8K | -8K -11.69% | 63,077 0.18% of shares | low |
| May 1, 2026 | Raykov Rosty Director | Exercise | Common shares | $38.2K | +16K +13.37% | 132,232 0.38% of shares | low |
| Apr 1, 2026 | Raykov Rosty Director | Exercise | Common shares | $38.2K | +16K +14.28% | 124,802 0.36% of shares | low |
| Mar 2, 2026 | Raykov Rosty Director | Exercise | Common shares | $38.2K | +16K +15.84% | 114,075 0.33% of shares | low |
| Feb 2, 2026 | Raykov Rosty Director | Exercise | Common shares | $38.2K | +16K +16.73% | 108,826 0.31% of shares | low |
| Jan 2, 2026 | Raykov Rosty Director | Exercise | Common shares | $38.2K | +16K +18.85% | 98,332 0.28% of shares | low |
| Jun 1, 2026 | Raykov Rosty Director | Exercise | Common shares | $38.2K | +16K +12.55% | 139,826 0.40% of shares | low |
| May 11, 2026 | Rallis Chris a Director | Exercise | Common Shares | $35.0K | +14K +25.13% | 71,423 0.21% of shares | low |
| Jan 7, 2026 | Andrade Robert Executive | Exercise | Common shares | $34.8K | +14K +8.02% | 191,100 0.55% of shares | low |
| Jan 23, 2026 | Andrade Robert Executive | Exercise | Common shares | $24.5K | +10K +4.97% | 211,100 0.61% of shares | low |
| Jan 15, 2026 | Andrade Robert Executive | Exercise | Common shares | $24.5K | +10K +5.23% | 201,100 0.58% of shares | low |
| Mar 26, 2026 | Cioffi Christiana Marie Executive | Exercise | Common shares | $19.9K | +5K | 4,700 0.01% of shares | low |
| Feb 18, 2026 | Andrade Robert Executive | Exercise | Common shares | $10.0K | +2K +1.15% | 215,108 0.62% of shares | low |
| May 31, 2026 | Raykov Rosty Director | Grant | Common shares | $0 | +3K +2.29% | 124,229 0.36% of shares | low |
| May 31, 2026 | Cioffi Christiana Marie Executive | Grant | Common shares | $0 | +156 +0.65% | 24,176 0.07% of shares | low |
| May 31, 2026 | Sayad Pierre Sargis Executive | Grant | Common Shares | $0 | +168 +0.81% | 21,015 0.06% of shares | low |
| May 31, 2026 | Evans Terry L Executive | Grant | Common Shares | $0 | +168 +0.81% | 21,015 0.06% of shares | low |
| May 31, 2026 | Hackman Jeffrey S. CEO | Grant | Common Shares | $0 | +1K +1.88% | 62,825 0.18% of shares | low |
| May 31, 2026 | Andrade Robert Executive | Grant | Common shares | $0 | +2K +0.59% | 289,269 0.83% of shares | low |
| Apr 30, 2026 | Cioffi Christiana Marie Executive | Exercise | Common shares | $0 | +155 +0.65% | 24,020 0.07% of shares | low |
| Apr 30, 2026 | Sayad Pierre Sargis Executive | Exercise | Common Shares | $0 | +168 +0.81% | 20,847 0.06% of shares | low |
| Apr 30, 2026 | Evans Terry L Executive | Exercise | Common Shares | $0 | +168 +0.81% | 20,847 0.06% of shares | low |
| Apr 30, 2026 | Hackman Jeffrey S. CEO | Exercise | Common Shares | $0 | +1K +1.92% | 61,666 0.18% of shares | low |
| Apr 30, 2026 | Raykov Rosty Director | Exercise | Common shares | $0 | +3K +2.44% | 116,634 0.34% of shares | low |
| Apr 30, 2026 | Andrade Robert Executive | Exercise | Common shares | $0 | +2K +0.60% | 287,566 0.83% of shares | low |
| Mar 28, 2026 | Cioffi Christiana Marie Executive | Exercise | Common shares | $0 | +2K +8.66% | 23,865 0.07% of shares | low |
| Mar 31, 2026 | Cioffi Christiana Marie Executive | Exercise | Common shares | $0 | +158 +0.72% | 21,964 0.06% of shares | low |
| Mar 31, 2026 | Cioffi Christiana Marie Executive | Exercise | Common shares | $0 | +17K +363.96% | 21,806 0.06% of shares | low |
| Mar 28, 2026 | Sayad Pierre Sargis Executive | Exercise | Common shares | $0 | +2K +11.02% | 20,679 0.06% of shares | low |
| Mar 31, 2026 | Sayad Pierre Sargis Executive | Exercise | Common shares | $0 | +171 +0.93% | 18,627 0.05% of shares | low |
| Mar 31, 2026 | Sayad Pierre Sargis Executive | Exercise | Common Shares | $0 | +18K | 18,456 0.05% of shares | low |
| Mar 28, 2026 | Evans Terry L Executive | Exercise | Common shares | $0 | +2K +11.02% | 20,679 0.06% of shares | low |
| Mar 31, 2026 | Evans Terry L Executive | Exercise | Common shares | $0 | +171 +0.93% | 18,627 0.05% of shares | low |
| Mar 31, 2026 | Evans Terry L Executive | Exercise | Common Shares | $0 | +18K | 18,456 0.05% of shares | low |
| Mar 28, 2026 | Hackman Jeffrey S. CEO | Exercise | Common Shares | $0 | +14K +29.94% | 60,507 0.17% of shares | low |
| Mar 31, 2026 | Hackman Jeffrey S. CEO | Exercise | Common Shares | $0 | +1K +2.55% | 46,564 0.13% of shares | low |
| Mar 31, 2026 | Hackman Jeffrey S. CEO | Exercise | Common Shares | $0 | +17K +58.15% | 45,405 0.13% of shares | low |
| Mar 31, 2026 | Raykov Rosty Director | Grant | Common shares | $0 | +5K +5.01% | 109,204 0.31% of shares | low |
| Mar 28, 2026 | Andrade Robert Executive | Exercise | Common shares | $0 | +12K +4.48% | 285,863 0.82% of shares | low |
| Mar 31, 2026 | Andrade Robert Executive | Exercise | Common shares | $0 | +2K +0.82% | 273,593 0.79% of shares | low |
| Mar 31, 2026 | Andrade Robert Executive | Exercise | Common shares | $0 | +15K +5.74% | 271,380 0.78% of shares | low |
| Feb 28, 2026 | Raykov Rosty Director | Grant | Common shares | $0 | +5K +5.01% | 109,204 0.31% of shares | low |
| Jan 31, 2026 | Raykov Rosty Director | Grant | Common shares | $0 | +5K +5.92% | 93,228 0.27% of shares | low |